HealthHelp’s Post

Unveiling the complexities of genetic testing: A significant 80% of variants in ClinVar are classified as VUS or conflicted. Discover how MAVEvidence by Constantiam Biosciences is pioneering the interpretation of these ambiguous genetic findings, enhancing diagnostic accuracy and advancing patient-centric care. #GeneticTesting #MAVEvidence #HealthTech #PatientCare #vus

The video for this programme is made with easy-to-follow schematics for simplified learning. It covers how & when to use PARP inhibitors. Expert Neal Shore considers the best PARPi monotherapy treatment choice based on genetic test results. 👀https://ow.ly/NMSV50Px0fz #MedEd

Learn about genomic testing from Valentin Prisecaru & Jeff Ingersoll of Diagnostic Solutions, which offers the Genomic Insight genomic health profile powered by the Opus23 Explorer: https://lnkd.in/g2JCHkjD

🌍 Imagine a world without genetic uncertainties. At Constantiam Biosciences, we are committed to making this vision a reality. Our innovative platform, MAVEvidence, transforms the way we interpret genetic variants, turning ambiguity into clarity and actionable insights. Together, we can pave the way for more precise and confident genetic diagnoses. #GeneticTesting #PrecisionMedicine #Innovation #MAVEvidence #GeneticClarity

🔬In recognition of May being the Cystic Fibrosis Awareness Month, we would like to bring attention to the efforts behind this genetic disease and how the structural information of CFTR, a key protein in cystic fibrosis research, has brought insights into future drug development research. Read how it was done and how it was recreated utilizing the 3decision software: 👉https://bit.ly/4dJRRd2 #SBDD #cysticfibrosis #3decision #drugdiscovery #Discngine

🔬 Exploring Hemoglobinopathy and Thalassemia Testing Are you curious about the evolving landscape of hemoglobinopathy? 🩸 Dr. Robert Akkers delves into this topic, shedding light on the shifting distribution of hemoglobinopathies and the critical need for expanded thalassemia genetic testing. 🧬 In a recent blog, Dr. Akkers shares how his lab streamlined thalassemia testing, leveraging real case data. The star of the show? Devyser’s dedicated software, Amplicon Suite, which enhances data analysis. 🌟

Are you be interested in learning about the shifting distribution of hemoglobinopathy, and the need for expanded thalassemia genetic testing? Read this insightful blog that recaps how Dr. Robert Akkers and his lab implemented more streamlined thalassemia testing and used real case data to showcase how Devyser’s dedicated software, Amplicon Suite, aids data analysis. Read here: https://bit.ly/3S8vQvf Click the link to discover more about the features in Amplicon Suite ▶️ https://bit.ly/3LoFoyr #NGSTesting #LabInnovation #thalassemia #ngs #genetictesting

Invitae Generation is our rigorous, evolving approach to clinical genetic testing. Since 2020, we’ve seen a 40% reduction in rates of variants of uncertain significance (VUS) with Invitae Generation technology. Learn more about how to get the answers you need for your patients when you need them: https://invit.ae/3KMoJEG

Healthcare providers and patients are increasingly relying on genetic testing to predict chronic disease risk, and as a result, demand for laboratory testing is exploding. An analysis of Avalon client data in 2023 revealed a 5 % increase in genetic test spend to $13.42 per member per year (PMPY) from $12.47 PMPY in 2022. Stay tuned for the release of the 2024 Lab Trend Report, which will include a proprietary analysis of the drivers of emerging industry trends, a closer look at the future of clinical laboratory testing, Avalon case studies where lab values created opportunities for delaying disease progression, and more. #AvalonHCS #Avalon #LabInsights #LabTrendReport

Mitochondrial DNA (mtDNA) testing plays a crucial role in diagnosing and guiding the treatment of mitochondrial genetic conditions, enabling patients to receive more tailored and effective healthcare. It also supports ongoing research and the development of potential therapies, offering hope for improved outcomes for those affected by these complex conditions. To learn more and start a test order, visit: https://bit.ly/3qkSgyM  To learn about mitochondrial conditions and the benefits of mtDNA testing, read our blog: https://bit.ly/47BjKBb  #ThinkBG #BGreat #Mitochondrial #mtDNA